IP Verse

Rna Containing Composition For Treatment Of Tumor Diseases - EP3173092

PATENT ANALYSIS

Patent Details

Grant Date
Jun 26, 2019
Company
CUREVAC AG
Oppositions

BIONTECH RNA PHARMACEUTICALS GMBH

ETHERNA IMMUNOTHERAPIES NV

FRIEDRICH, RAINER

KONIG SZYNKA TILMANN VON RENESSE

SANOFI

More patents of Curevac Ag

EP4023755

EP3521456

EP3708668

Want to monitor this patent?

Feel free to send us a message here and we will get back to you